Old Web
English
Sign In
Acemap
>
Paper
>
Management of a High-Risk Surgery with Emicizumab and Factor VIII in a Child with a Severe Hemophilia A and Inhibitor.
Management of a High-Risk Surgery with Emicizumab and Factor VIII in a Child with a Severe Hemophilia A and Inhibitor.
2021
Charles R. Lefevre
Anaïs Jaffré
Adeline Pontis
Fabienne Nedelec-Gac
Pierre Gueret
Isabelle Gouin-Thibault
Bernard Fraisse
Sophie Bayart
Benoît Guillet
Keywords:
Emicizumab
Severe hemophilia A
MEDLINE
Pediatrics
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
13
References
0
Citations
NaN
KQI
[]